LOGO.png
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
July 30, 2021 09:49 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, July 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) The scientific and technical council of the Agency for the Development of the Pharmaceutical Industry of...
LOGO.png
Rafarma’s Global Pharmaceutical Strategy At A Glance
May 18, 2021 08:53 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern...
Rafarma To Expand Proton Therapy Centers
May 07, 2021 09:35 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey)...
Rafarma and Haifa Technopark Enter Talks for Joint Venture
April 30, 2021 09:31 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan...
LOGO.png
Rafarma Embarks on Aggressive Global Partnerships Plan
March 04, 2021 10:55 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given...
LOGO.png
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
January 29, 2021 10:30 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development...
LOGO.png
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer
December 09, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the previously-announced Biocogency...
LOGO.png
Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia
December 01, 2020 10:53 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia (https://vaccineslab.com/). ...
LOGO.png
Letter To Shareholders from Chairman Ilya Shpurov
November 09, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus , Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov:...
LOGO.png
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger
November 04, 2020 09:01 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that the elite Chicago auditing firm LJ Soldinger Associates...